Failure of recombinant stem cell factor to enhance engraftment of L-leucyl-L-leucine methyl ester treated canine marrow after irradiation.
Kiem
H P
HP
Leisenring
W
W
Raff
R
R
Deeg
H J
HJ
Schuening
F G
FG
Appelbaum
F R
FR
Storb
R
R
D000818:Animals; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D016465:Bone Marrow Purging / Q000379:methods*; D016026:Bone Marrow Transplantation; D004151:Dipeptides / Q000494:pharmacology / Q000627:therapeutic use*; D004285:Dogs; D006085:Graft Survival / Q000187:drug effects*; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000473:pathology; D015395:Histocompatibility Antigens Class I / Q000276:immunology; D051379:Mice; D011828:Radiation Chimera; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D013045:Species Specificity; D019089:Stem Cell Factor / Q000494:pharmacology / Q000627:therapeutic use*; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects; D017211:Treatment Failure
D004151:Dipeptides; D015395:Histocompatibility Antigens Class I; D011994:Recombinant Proteins; D019089:Stem Cell Factor; C039692:histocompatibility antigen DLA; C045139:leucyl-leucine-methyl ester